Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

NCT ID: NCT06420505

Last Updated: 2024-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-29

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Artery Coronary Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Coronary Intervention

The Vivo ISAR is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years old
* Ability to provide signed informed consent form.
* Male or non-pregnant female patient (Pregnancy status to be confirmed verbally from the female patient of reproductive age)
* Presentation with acute coronary syndrome or chronic coronary syndrome with stable angina or angina equivalent symptoms or with a positive noninvasive test for ischemia or evidence of a functionally significant coronary stenosis.
* Patient having social security number.
* Patient treated only with Vivo ISAR stent in case of single or multiple vessel stenting

Exclusion Criteria

* Concurrent participation in another clinical trial.
* Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR.
* Planned elective surgery in next 6 months
* Cardiogenic shock/ hemodynamically unstable patients
* Concurrent medical condition with a life expectancy of less than 12 months
* History of cerebrovascular accident in the last 6 months.
* Vulnerable patient under guardianship or curatorship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EVAMED

OTHER

Sponsor Role collaborator

Translumina GmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thibault Lhermusier, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Axium

Aix-en-Provence, , France

Site Status RECRUITING

CHU CAEN

Caen, , France

Site Status NOT_YET_RECRUITING

Hôpital A. Schweitzer - GHCA

Colmar, , France

Site Status RECRUITING

Clinique Louis Pasteur

Essey-lès-Nancy, , France

Site Status RECRUITING

CH Haguenau

Haguenau, , France

Site Status RECRUITING

CHU La Timone

Marseille, , France

Site Status RECRUITING

Hopital Nord

Marseille, , France

Site Status NOT_YET_RECRUITING

HP Jacques Cartier

Massy, , France

Site Status RECRUITING

Clinique Pont de Chaume

Montauban, , France

Site Status NOT_YET_RECRUITING

Hôpital Privé du Confluent

Nantes, , France

Site Status RECRUITING

Polyclinique Les Fleurs

Ollioules, , France

Site Status RECRUITING

APHP

Paris, , France

Site Status NOT_YET_RECRUITING

HP Claude Galien

Quincy-sous-Sénart, , France

Site Status NOT_YET_RECRUITING

CHU Reims

Reims, , France

Site Status RECRUITING

Clinique Saint Hilaire

Rouen, , France

Site Status RECRUITING

CHRU Strasbourg

Strasbourg, , France

Site Status NOT_YET_RECRUITING

CH de Bigorre

Tarbes, , France

Site Status RECRUITING

Clinique Pasteur

Toulouse, , France

Site Status NOT_YET_RECRUITING

Chu Toulouse

Toulouse, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Béatrice GODEFROY

Role: CONTACT

0623822906 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Luc Maillard, Dr

Role: primary

Farzin Begui, Pr

Role: primary

Amine Matari, Dr

Role: primary

Julien Lemoine, Dr

Role: primary

Fabien DE POLI, Dr

Role: primary

Thomas Cuisset, Pr

Role: primary

Laurent Bonello, Pr

Role: primary

Philippe Garot, Dr

Role: primary

Romain André, Dr

Role: primary

Ashok Tirouvanziam, Dr

Role: primary

La Scala, Dr

Role: primary

Gille Montalescot, Dr

Role: primary

Thierry Unterseeh, Dr

Role: primary

Laurent Faroux, Dr

Role: primary

Matthieu Godin, Dr

Role: primary

Olivier Morel, Pr

Role: primary

Majdi Abdennadher, Dr

Role: primary

Didier Tchétché, Dr

Role: primary

Thibault Lhermusier, Pr

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRANSLUMINA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.